Physician profile
Ami White
NPI 1376806331
$311.27
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $269 · 2022: $42.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.51 | 2021-2022 | |
| Boston Scientific Corporation | $52.95 | 2021 | |
| Lilly USA, LLC | $46.52 | 2021 | |
| Eisai INC. | $23.05 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $16.88 | 2021 | |
| Abbott Laboratories | $16.45 | 2021 | |
| Apria Healthcare LLC | $15.29 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.54 | 2021 | |
| Novo Nordisk INC | $12.53 | 2021 | |
| Dexcom, INC. | $11.55 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ami White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.